Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Treatment group</td><td align="center">No. animals</td><td align="center">No. animals with tumors</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">DMBA</td><td align="center">10</td><td align="center">0</td></tr><tr><td align="left">GW501516</td><td align="center">10</td><td align="center">0</td></tr><tr><td align="left">DMBA + GW501516</td><td align="center">15</td><td align="center">12</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Gastric tumor occurrence after treatment with DMBA and GW501516.

PPAR Research

tab1

Table 1

Table 1: Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation 